美国 · 经济杂志 · Quartz

Apothecary Pharma is recalling 22 vials of weight loss drug over sterility concerns

来源：Quartz · 美国 2 小时前

The company received an FDA warning letter in December 2025 citing deficiencies in how it makes sterile drug products

在 Quartz 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (qz.com)

推荐阅读

The Hidden Costs of Covered-Call ETFs

No wonder the White House wants Warsh to cut: A 1% Fed rate hike costs the Treasury an extra $95 billion a year in national debt interest

Alexa von Tobel’s Inspired Capital Backed 10 Unicorns. Its New $450 Million Fund Targets 1 Kind of Founder

‘You Can See Everything’ perfectly captures what a decade of post-truth has done to us

Millennials Are Satisfied At Work Because They Stopped Expecting More

Take your drinks on a bus to the Chiefs game